Phase I Study of GSK2982772 in Japanese Healthy Male Participants

NCT03590613 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Autoimmune Diseases

Interventions

DRUG: GSK2982772
DRUG: Placebo

Sponsor

GlaxoSmithKline